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http://www.biomedcentral.com/1471-2318/13/12RESEARCH ARTICLE Open AccessCommunity acquired infections in older patients
admitted to hospital from care homes versus the
community: cohort study of microbiology and
outcomes
Charis Marwick1*, Virginia Hernandez Santiago1, Colin McCowan2, Janice Broomhall1 and Peter Davey1Abstract
Background: Residents of care homes are at risk of colonisation and infection with antibiotic resistant bacteria, but
there is little evidence that antibiotic resistance among such patients is associated with worse outcomes than
among older people living in their own homes. Our aim was to compare the prevalence of antibiotic resistant
bacteria and clinical outcomes in older patients admitted to hospital with acute infections from care homes versus
their own homes.
Methods: We enrolled patients admitted to Ninewells Hospital in 2005 who were older than 64 years with onset of
acute community acquired respiratory tract, urinary tract or skin and soft tissue infections, and with at least one
sample sent for culture. The primary outcome was 30 day mortality, adjusted for age, sex, Charlson Index of co-
morbidity, sepsis severity, presence of resistant isolates and resistance to initial therapy.
Results: 161 patients were identified, 60 from care homes and 101 from the community. Care home patients were
older, had more co-morbidities, and higher rates of resistant bacteria, including MRSA and Gram negative
organisms resistant to co-amoxiclav, cefuroxime and/or ciprofloxacin, overall (70% versus 36%, p = 0.026). 30 day
mortality was high in both groups (30% in care home patients and 24% in comparators). In multivariate logistic
regression we found that place of residence did not predict 30 day mortality (adjusted odds ratio (OR) for own
home versus care home 1.01, 95% CI 0.40-2.52, p = 0.984). Only having severe sepsis predicted 30 day mortality (OR
10.09, 95% CI 3.37-30.19, p < 0.001), after adjustment for age, sex, co-morbidity, presence of resistant bacteria,
resistance to initial therapy, and place of residence.
Conclusions: Older patients admitted with acute infection had high 30 day mortality. Patients from care homes
were more likely to have resistant organisms but high levels of antimicrobial resistance were found in both groups.
Thus, we recommend that antibiotic therapies active against resistant organisms, guided by local resistance
patterns, should be considered for all older patients admitted with severe sepsis regardless of their place of
residence.
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Residents of care homes are at risk of colonisation and
infection with antibiotic resistant bacteria [1], especially
meticillin resistant Staphylococcus aureus (MRSA) [2]
and cephalosporin or quinolone resistant Gram negative
bacteria [3,4]. A study from Ohio showed that the inci-
dence of MRSA infection was increasing faster in nurs-
ing home residents than in hospital inpatients. In
comparison with 2006 the incidence of MRSA in 2007
increased among nursing home residents by 183%
whereas the increase for inpatients was only 58% [5].
There are several factors that may explain the increasing
prevalence of antibiotic resistant bacteria in care homes.
These include the fact that they are a closed environ-
ment which might facilitate the spread of infection. Resi-
dents are usually older, multi-morbid and vulnerable,
and likely to have indwelling devices. They are fre-
quently admitted to hospitals, with a greater risk of col-
onisation with, and transmission of, resistant organisms
from acute care facilities [1]. In addition, 50-75% resi-
dents in long-term care facilities are exposed to at least
one course of antibiotics each year [6].
The objective of this study was to compare the preva-
lence of antibiotic resistance and clinical outcomes in older
patients admitted with acute infections from care homes
versus the community using a retrospective cohort design.
Methods
Cohort definition
We conducted a retrospective cohort study. The study
population consisted of residents of the Tayside region in
Scotland aged 65 or over in 2005 who were admitted to
Ninewells Hospital between 1st January and 31st December
2005, had at least one sample sent for culture, and were
either; i) discharged with an ICD 10 code for lower respira-
tory tract infection (LRTI), skin and soft tissue infection
(SSTI), or urinary tract infection (UTI), or ii) identified
opportunistically during screening for related cohort
studies. Ninewells Hospital is an 850-bed teaching hospital
serving a population of approximately 400,000 people.
We identified study subjects by searching the Scottish
Morbidity Records database of hospital admissions
(SMR01) for admissions of patients over 64 years old in
2005 with pre-specified ICD 10 discharge codes. The
ICD 10 discharge codes used were J13-15, J18.1, J18.9,
J22 for lower respiratory tract infections; L031, L97X,
M6008, M86, R02X, S913, T131, T814, T874 for skin
and soft tissue infections; N309, N390 for urinary infec-
tions. Case notes were obtained and patients were
included if the presence of infection was documented,
and the patient received antibiotic treatment, within
three days after admission to hospital.
Additional study subjects who met the above criteria,
with the exception of the ICD 10 discharge codes, wereidentified opportunistically during case note screening
for two related cohort studies; one study of patients with
intra-abdominal infections, and one of patients who had
blood cultures taken but had no ICD 10 discharge codes
for infection.
Data sources
The Health Informatics Centre (HIC) is a partnership
between NHS Tayside, NHS Fife and the University of
Dundee. It allows linkage of individual patient data from
different electronic datasets, including hospital admis-
sion data (Scottish Morbidity Record, SMR01), mortality
data (through the National Register of Deaths, GRO),
demographic data, microbiology data (from Central Vi-
sion, the information system that contains the results of
all laboratory and radiology investigations performed in
NHS Tayside) and prescribing information from com-
munity pharmacies.
Data extraction, linkage and analysis
The exposure variable was residence in a nursing or resi-
dential home, collectively termed care homes. The
addresses for all nursing and residential homes were
taken from Health Board records and any patient who
was registered at one of these addresses was identified as
a care home resident.
The primary outcome was death, in or outside hos-
pital, within 30 days of admission with infection. This
was ascertained from the National Register of Deaths.
Covariates for the mortality analysis were place of resi-
dence, sepsis severity, resistance of isolates, age, sex and
Charlson Index of co-morbidity [7].
A Charlson Index of co-morbidity was calculated for
each individual from hospital discharge codes for the
current admission and any other admissions in the pre-
vious year. Case note reviews were performed to extract
details about evidence of site (LRTI, SSTI, UTI or other)
and severity of infection. We used a previously published
method to stratify severity of infection according to mar-
kers of sepsis (presence of the systemic inflammatory re-
sponse syndrome in the context of infection) [8] and
severe sepsis (Standardised Early Warning System score
≥4) [9].
Microbiological information including sensitivity data
were obtained from Central Vision.
Data about initial antimicrobial therapy and results of
all microbiology tests were reviewed independently by
two Infectious Diseases physicians (CM and PD) in
order to address three questions about each microbial
isolate from cultures:
1. Was the isolate clinically significant?
2. If significant, was it a “resistant” pathogen, i.e.
meticillin resistant Staphylococcus aureus (MRSA), or
Marwick et al. BMC Geriatrics 2013, 13:12 Page 3 of 6
http://www.biomedcentral.com/1471-2318/13/12Gram negative bacteria resistant to cefuroxime, co-
amoxiclav and/or ciprofloxacin?
3. If significant, was it sensitive to at least one
antimicrobial included in the initial therapy?
Decisions about the clinical significance of each micro-
bial isolate were made depending on the site of culture.
Blood cultures: all isolates were coded as clinically signifi-
cant with the exception of coagulase-negative staphylo-
cocci. Skin: only Staphylococcus aureus (S. aureus) isolates
were coded as clinically significant, as there were no
streptococci isolated from any skin samples in the study.
Sputum: Streptococcus pneumoniae, S. aureus, Haemophi-
lus influenzae, Moraxella catarhalis, Klebsiella spp.
Pseudomonas spp. and Stenotrophomonas maltophilia
were classified as clinically significant, and other isolates
(e.g. Escherichia coli (E. coli) or other coliforms) were clas-
sified as not significant. Urine: all isolates were coded as
clinically significant.Statistical analysis
Proportions or means with 95% confidence intervals (CI)
were reported as appropriate. Differences in proportions
between groups were examined using the chi-squared
test, and means using the student t-test, with the test re-
sult, degrees of freedom and p-value reported. Odds
ratios (OR) for 30 day mortality were calculated by uni-
variate and multivariate logistic regression models
adjusted for age, gender, co-morbidity, severity of sepsis,
presence of a resistant organism, resistance to initial
therapy and place of residence. All data were analysed in
Stata Version 10 (StataCorp. 2007. Stata Statistical Soft-
ware: Release 10. College Station, TX: StataCorp LP).Ethics
Ethics approval was not required for this study as we
used data from electronic and paper hospital records
and followed the HIC Standard Operating Procedure,
which is pre-approved by the NHS Research Ethics
Committee. The protocol was approved by the Caldicott
Guardian for hospital inpatients.Results
We identified 161 valid cases of community acquired
infections in patients aged 65 years and over in 2005
with at least one sample sent for microbiology. Of these,
101 (63%) were resident in their own homes and 60
(37%) were in care homes. Residents of care homes were
significantly older (χ2 = 14.95, df = 3, p = 0.002) and had
significantly higher Charlson co-morbidity indices (χ2 =
6.07, df = 2, p = 0.048) than patients who were resident
in their own homes (Table 1). The most common co-morbidities were cerebrovascular disease, diabetes,
chronic pulmonary disease and myocardial infarction.
The most common sites of infection were the lower
respiratory tract for patients admitted from their own
home and the urinary tract for patients admitted from
care homes (Table 1), but the overall distribution of sites
of infection was similar for both groups of patients (χ2 =
6.00, df = 4, p = 0.199). Forty five patients had 62 clinic-
ally significant bacterial isolates; 23 patients (38%) from
care homes and 22 patients (22%) from their own home
(χ2 = 5.12, df = 1, p = 0.024) (Table 1). The commonest
organisms isolated were: S. aureus and E. coli. Patients
from care homes were significantly more likely to have
MRSA if S. aureus was isolated (10/12 (83%) versus 4/11
(36%) isolates, respectively, (χ2 = 5.32, df = 1, p = 0.02)).
A higher proportion of care home residents had resistant
Gram negative organisms but the difference was not sig-
nificant. Having any resistant organism was significantly
more common among care home residents (Table 1).
Twenty four of 45 (53%) patients received antimicrobial
therapy that did not cover all the organisms isolated from
that patient. This was more common among care home
residents (61%) than those from their own home (45%),
but the difference was not statistically significant (χ2 =
1.07, df = 1, p = 0.300). Of the 24 patients with isolates that
were resistant to their initial antimicrobial therapy, the
isolates were MRSA in 14 (58%) cases, and Gram negative
bacteria resistant to cefuroxime, co-amoxiclav and/or
ciprofloxacin in 7 (29%) cases. In the remaining three
cases the isolates resistant to initial therapy were; amoxi-
cillin sensitive Enterococcus faecalis treated with cefurox-
ime, meticillin sensitive S. aureus treated with amoxicillin,
and penicillin sensitive S. pneumoniae treated with cipro-
floxacin. The 24 isolates that were resistant to empirical
therapy came from blood (11 isolates), skin (7 isolates),
urine (4 isolates) and sputum (2 isolates). All of these iso-
lates were sensitive to the combination of amoxicillin,
gentamicin and metronidazole.
Indicators of sepsis or severe sepsis were present in 41
(41%) and 15 (15%) patients resident in their own home,
and 21 (35%) and 18 (30%) patients resident in care
homes, respectively, with no significant difference be-
tween the groups (χ2 = 5.36, df = 2, p = 0.069). Significant
organisms were isolated from nine (27%) of the 33
patients with severe sepsis. The organism was MRSA in
four (12% of 33) cases, Morganella morganii in two (6%)
cases, and Streptococcus pneumoniae, Klebsiella pneu-
moniae, Pseudomonas aeruginosa, and Escherichia coli,
each in one case. Three of the Gram negative isolates
were classified as resistant organisms, and one patient
had both MRSA and a resistant Morganella morganii,
meaning that overall six (18% of 33) patients with severe
sepsis had resistant organisms. This was not significantly
different from the 14% (18/128) of patients without
Table 1 Demographic details, infection site and microbiological isolates
Demographic variables Own home Care home p value (X2 test) Total
No. of patients 101 60 161
Age (years): 65-69 18 (18%) 6 (10%) 0.002 24 (15%)
70-79 44 (44%) 12 (20%) 56 (35%)
80-89 31 (31%) 34 (57%) 65 (40%)
90+ 8 (8%) 8 (13%) 16 (10%)
Male gender 49 (49%) 25 (42%) 0.399 74 (46%)
Charlson Index*: 0 24 (24%) 9 (15%) 0.048 33 (20%)
1-2 61 (60%) 32 (53%) 93 (58%)
3+ 16 (16%) 19 (32%) 35 (22%)
Site of infection **
LRTI 29 (29%) 13 (22%) 0.199 42 (26%)
SSTI 20 (20%) 12 (20%) 32 (20%)
UTI 24 (24%) 20 (33%) 44 (27%)
Other 23 (23%) 8 (13%) 31 (19%)
Multiple 5 (5%) 7 (12%) 12 (7%)
Microbiological isolates
No. of patients 22 23 45
S. aureus 11 (50%) 12 (52%) 0.884 23 (51%)
MRSA 4 (18%) 10 (43%) 0.067 14 (31%)
Gram negative 10 (45%) 12 (52%) 0.652 22 (49%)
Resistant Gram negative *** 4 (18%) 8 (35%) 0.208 12 (27%)
Any resistant organism 8 (36%) 16 (70%) 0.026 24 (53%)
Resistant to initial therapy 8 (36%) 13 (57%) 0.175 21 (47%)
*Charlson Index of comorbidity [7].
**LRTI, lower respiratory infection; SSTI, skin and soft tissue infection; UTI, urinary tract infection; Other infections include intra-abdominal infections, bone/joint
infections, and bacteraemia with undefined source.
***Resistant Gram negative bacteria were resistant to cefuroxime, co-amoxiclav or ciprofloxacin. Two patients had both MRSA and resistant Gram
negative bacteria.
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= 1, p = 0.554).
There were 42 (26%) patients who died within 30 days
of admission to hospital, 24 (24%) among those resident
in their own home, and 18 (30%) resident in care homes,
with no significant difference between the groups (χ2 =
0.76, df = 1, p = 0.383). Among those who died, 10 (24%)
had resistant organisms isolated, 3/24 (13%) admitted
from their own home and 7/18 (39%) admitted from
care homes (χ2 =3.95, df = 1, p = 0.070). There was no
difference between mean lengths of stay (t = −0.058, df =
157, p = 0.953) among patients admitted from care
homes (14.8 days, 95% CI 9.4-19.8) and from their own
home (14.6 days, 95% CI 10.5-19.2). In univariate ana-
lysis the only significant predictor of 30 day mortality
was having severe sepsis (OR 8.60, 95% CI 3.21-23.02, p
< 0.001, compared to no sepsis), and this was even stron-
ger (adjusted OR 10.09, 95% CI 3.37-30.19, p < 0.001)
after adjustment for age, sex, co-morbidity, resistance of
organisms and place of residence in multivariateregression (Table 2). We found that place of residence
did not predict 30 day mortality (adjusted OR for own
home versus care home 1.01, 95% CI 0.40-2.52, p =
0.984). Isolation of resistant bacteria was associated with
higher mortality but the differences were not statistically
significant (Table 2).Discussion
There is growing evidence about the increasing preva-
lence of multi drug resistant bacteria in care homes or
long term care facilities. However, this is the first study
to compare the prevalence of resistance and the clinical
outcomes of older patients presenting to hospital with
infection from care homes versus their own homes. We
found that care home residents were older and likely to
have more co-morbidity. Residence in a long-term care
facility was also associated with a higher prevalence of
resistant organisms, which might be associated with a
greater exposure to antibiotics in this setting. However,
Table 2 Odds ratios with 95% CI and p-values for 30 day mortality by variable*
Variable Odds ratios for death within 30 days
(95% CI and p value)
Unadjusted Adjusted
Own home (versus care home) 1.38 (0.67 - 2.82, p = 0.384) 1.01 (0.40 - 2.52, p = 0.984)
Sepsis (versus no sepsis) 1.85 (0.74 - 4.64, p = 0.192) 1.75 (0.67 - 4.59, p = 0.254)
Severe sepsis (versus no sepsis) 8.60 (3.21 - 23.02, p < 0.001) 10.09 (3.37 - 30.19, p < 0.001)
Any resistant organism (versus no resistant organism isolated) 1.89 (0.76 - 4.72, p = 0.172) 2.10 (0.26 - 16.77, p = 0.486)
Resistant to initial therapy (versus not resistant) 1.92 (0.73 - 5.02, p = 0.184) 0.64 (0.07 - 5.85, p = 0.696
*Patients aged 90+ were at greater risk of 30 day mortality than the youngest age group but otherwise there was no significant effect of age, gender
or co-morbidity.
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terminant of outcome.
A recent study from Australia compared bacterial iso-
lates and antibiotic resistance in elderly patients from
care homes and the community but did not measure
clinical outcome [10]. Their study population was also
restricted to patients aged ≥ 65 years but, unlike our
study, they included patients presenting to ambulatory
care settings (Accident and Emergency or Outpatients)
that were not admitted to hospital. Their results were
broadly similar to our study in that there were higher
proportions of antibiotic resistance among some bacteria
in nursing home patients, especially meticillin resistance
among S. aureus isolates across all specimen types, and
resistance to several empiric antibiotics among Gram
negative isolates in urine cultures [10]. A study from the
USA compared clinical outcomes in patients with isola-
tion of antibiotic resistant versus sensitive bacteria who
were transferred from long-term care facilities and ad-
mitted to acute-care hospitals, but did not include
patients admitted from their own homes [11]. That
study included 153 patients with positive microbiology
and 42 (27%) received an initial regimen to which their
isolate was resistant. As in our study, they found that
neither infection with antibiotic resistant bacteria nor
appropriateness of initial treatment regimen was signifi-
cantly related to outcome.
The limitations of our study include those common to
all retrospective cohorts, such as case ascertainment bias
when using hospital discharge codes. In addition, the
clinical data available, including microbiological samples,
were limited to that carried out as part of routine care.
The number of eligible patients for our study was small
which was at least in part due to the relatively small pro-
portion of patients who had microbiological samples
taken, and the even smaller proportion with a candidate
organism isolated. The small numbers limited the power
of the study, especially in adjusted analyses. We were
unable to determine the timing of microbiological sam-
pling in relation to the timing of antibiotic administra-
tion, so prior antibiotic therapy might have limited thenumber of positive samples. Studies consistently report
that microbiological diagnoses are made in low propor-
tions of septic patients. Even among patients with septic
shock in intensive care only 70% had a plausible micro-
biological isolate [12], and we included patients who did
not meet sepsis criteria so the low yield was not surpris-
ing. Antibiotic exposure prior to admission, which we
did not record, may also have had an effect on resistance
on admission to hospital. However, neither the bacteria
isolated nor antimicrobial resistance were associated
with a significant difference in outcome. We were unable
to determine the time to antibiotic therapy, or other
aspects of sepsis management such as fluid resuscitation,
that may have impacted on patient outcome. An
updated, larger, prospective study that incorporates more
detailed clinical management data would shed further
light on the impact of antibiotic resistance on outcome.Conclusions
Older patients hospitalised with acute infection had high
30 day mortality. This was 17% even in patients without
sepsis and rose to 64% in patients with severe sepsis.
When a candidate organism was isolated, there were
high levels of antimicrobial resistance in both care home
residents and patients resident in their own home. We
recommend that therapies active against resistant organ-
isms, guided by local prevalence and resistance data,
should be considered for all older patients admitted with
severe sepsis, and that place of residence should not
alter the choice of empiric antimicrobial regimen.
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